Research ExplorerPublicationsLymph node dissection during radical cystectomy for bladder ...

Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent

Standard

Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent. / Weisbach, Lars; Dahlem, Roland; Simone, Giuseppe; Hansen, Jens; Soave, Armin; Engel, Oliver; Chun, Felix K; Shariat, Shahrokh F; Fisch, Margit; Rink, Michael.

In: INT UROL NEPHROL, Vol. 45, No. 6, 01.12.2013, p. 1561-7.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Weisbach, L, Dahlem, R, Simone, G, Hansen, J, Soave, A, Engel, O, Chun, FK, Shariat, SF, Fisch, M & Rink, M 2013, 'Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent', INT UROL NEPHROL, vol. 45, no. 6, pp. 1561-7. https://doi.org/10.1007/s11255-013-0503-2

APA

Weisbach, L., Dahlem, R., Simone, G., Hansen, J., Soave, A., Engel, O., Chun, F. K., Shariat, S. F., Fisch, M., & Rink, M. (2013). Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent. INT UROL NEPHROL, 45(6), 1561-7. https://doi.org/10.1007/s11255-013-0503-2

Vancouver

Weisbach L, Dahlem R, Simone G, Hansen J, Soave A, Engel O et al. Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent. INT UROL NEPHROL. 2013 Dec 1;45(6):1561-7. https://doi.org/10.1007/s11255-013-0503-2

Bibtex

@article{a1b2e8cd6062434881775d9bb795b222,
title = "Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent",
abstract = "Despite advances in the surgical and medical treatment for urothelial carcinoma of the bladder (UCB), there have only been limited improvements in disease-specific mortality rates over the past decades. Lymph node dissection (LND) during radical cystectomy is an integral part of the treatment for muscle-invasive and high-risk UCB. LND may detect and remove lymph node (LN) metastasis and thus guide patient counseling and decision making regarding additional treatment decisions. In addition, LND may improve survival in patients both with and without LN metastasis. In this non-systematic review article, we discuss benefits and risks of LND, the role of limited versus extended LND and the dilemma of preoperative LN staging.",
author = "Lars Weisbach and Roland Dahlem and Giuseppe Simone and Jens Hansen and Armin Soave and Oliver Engel and Chun, {Felix K} and Shariat, {Shahrokh F} and Margit Fisch and Michael Rink",
year = "2013",
month = dec,
day = "1",
doi = "10.1007/s11255-013-0503-2",
language = "English",
volume = "45",
pages = "1561--7",
journal = "INT UROL NEPHROL",
issn = "0301-1623",
publisher = "Springer Netherlands",
number = "6",

}

RIS

TY - JOUR

T1 - Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent

AU - Weisbach, Lars

AU - Dahlem, Roland

AU - Simone, Giuseppe

AU - Hansen, Jens

AU - Soave, Armin

AU - Engel, Oliver

AU - Chun, Felix K

AU - Shariat, Shahrokh F

AU - Fisch, Margit

AU - Rink, Michael

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Despite advances in the surgical and medical treatment for urothelial carcinoma of the bladder (UCB), there have only been limited improvements in disease-specific mortality rates over the past decades. Lymph node dissection (LND) during radical cystectomy is an integral part of the treatment for muscle-invasive and high-risk UCB. LND may detect and remove lymph node (LN) metastasis and thus guide patient counseling and decision making regarding additional treatment decisions. In addition, LND may improve survival in patients both with and without LN metastasis. In this non-systematic review article, we discuss benefits and risks of LND, the role of limited versus extended LND and the dilemma of preoperative LN staging.

AB - Despite advances in the surgical and medical treatment for urothelial carcinoma of the bladder (UCB), there have only been limited improvements in disease-specific mortality rates over the past decades. Lymph node dissection (LND) during radical cystectomy is an integral part of the treatment for muscle-invasive and high-risk UCB. LND may detect and remove lymph node (LN) metastasis and thus guide patient counseling and decision making regarding additional treatment decisions. In addition, LND may improve survival in patients both with and without LN metastasis. In this non-systematic review article, we discuss benefits and risks of LND, the role of limited versus extended LND and the dilemma of preoperative LN staging.

U2 - 10.1007/s11255-013-0503-2

DO - 10.1007/s11255-013-0503-2

M3 - SCORING: Journal article

C2 - 23884728

VL - 45

SP - 1561

EP - 1567

JO - INT UROL NEPHROL

JF - INT UROL NEPHROL

SN - 0301-1623

IS - 6

ER -